Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Edwards Lifesciences has opened its new heart valve manufacturing facility in Changi North Crescent, Singapore.
Subscribe to our email newsletter
The state-of-the-art facility produces Edwards’s Carpentier-Edwards Perimount tissue heart valve replacements, and also serves as the headquarters for Edwards’s Asia-Pacific operations.
Donald Bobo, Jr, corporate vice president of heart valve therapy at Edwards, said: “Edwards’s new Singapore facility was developed to meet the global demands for our technologically advanced tissue heart valve replacement products. We look forward to serving more patients around the world through our heart valve operations in the US, Switzerland, and now, Singapore.”